Stanley Laman Group Ltd. Reduces Stock Position in CME Group Inc (NASDAQ:CME)

Stanley Laman Group Ltd. lowered its position in shares of CME Group Inc (NASDAQ:CME) by 3.4% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,408 shares of the financial services provider’s stock after selling 405 shares during the period. Stanley Laman Group Ltd.’s holdings in CME Group were worth $2,214,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CME. Truvestments Capital LLC bought a new position in CME Group in the 1st quarter worth $32,000. Close Asset Management Ltd bought a new position in CME Group in the 1st quarter worth $34,000. Advantage Investment Management LLC raised its holdings in CME Group by 119.0% in the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Westside Investment Management Inc. bought a new position in CME Group in the 2nd quarter worth $38,000. Finally, Permanens Capital L.P. bought a new position in CME Group in the 1st quarter worth $41,000. 84.44% of the stock is owned by institutional investors and hedge funds.

In related news, Director Elizabeth A. Cook sold 300 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $204.27, for a total transaction of $61,281.00. Following the sale, the director now directly owns 20,821 shares of the company’s stock, valued at approximately $4,253,105.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kathleen M. Cronin sold 4,960 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total transaction of $925,982.40. Following the sale, the insider now directly owns 49,337 shares in the company, valued at $9,210,724.53. The disclosure for this sale can be found here. Insiders have sold a total of 82,363 shares of company stock worth $16,429,225 over the last three months. 1.20% of the stock is currently owned by insiders.

CME has been the subject of several research reports. UBS Group upped their price objective on shares of CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. Wells Fargo & Co upped their price objective on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. ValuEngine upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Citigroup set a $202.00 price target on shares of CME Group and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Finally, Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research note on Monday, May 27th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $194.00.

Shares of CME Group stock traded down $3.27 during trading on Wednesday, hitting $210.03. The company’s stock had a trading volume of 50,931 shares, compared to its average volume of 1,619,637. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. The business’s fifty day moving average price is $203.45. The firm has a market capitalization of $75.44 billion, a P/E ratio of 30.88, a PEG ratio of 4.82 and a beta of 0.23. CME Group Inc has a 52 week low of $161.05 and a 52 week high of $216.73.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the business earned $1.74 EPS. As a group, equities research analysts anticipate that CME Group Inc will post 6.66 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be paid a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.43%. CME Group’s payout ratio is 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Support Level

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.